FIELD: organic chemistry; pharmacology.
SUBSTANCE: invention is directed to the development of new agents for the control of metabolic disorders. The use of the compound 1a-e of the following structure as an agent to increase the sensitivity of tissues to insulin in type 2 diabetes mellitus is disclosed.
EFFECT: invention provides an effective increase in tissue sensitivity to insulin in type 2 diabetes mellitus.
1 cl, 8 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| (2S)-3-(4-{2-[4-(2-{[(1R,4AR,7S)-7-ETHYNYL-1,4A,7-TRIMETHYL-1,2,3,4,4A,4B,5,6,7,8,10,10A-DODECAHYDROPHENANTHREN-1-YL]FORMAMIDO}ETHOXY)PHENYL]ETHOXY}PHENYL)-2-ETHOXY-PROPANOIC ACID FOR THERAPY AND PREVENTION OF METABOLIC SYNDROME | 2023 |
|
RU2813464C1 |
| N-[3-OXOLUP-28-OYL]-2-(4-(2-(4-((S)-2-ETHOXY-3-PROPANOYL)PHENOXY)ETHYL)PHENOXY)ETHANAMIDE FOR TREATING AND PREVENTING METABOLIC SYNDROME | 2021 |
|
RU2774591C1 |
| QUINOLINE DERIVATIVES | 1995 |
|
RU2137770C1 |
| CHEMICAL SYNTHESIS AND ANTI-TUMOR AND ANTI-METASTATIC EFFECTS OF CONJUGATE OF DOUBLE ACTION | 2011 |
|
RU2729419C2 |
| DERIVANT OF ACETAMID N-(1S)-1',2',3'-TRIMETHOXY-6,7-DIHYDRO-1H-BENZO[5',6':5,4]CYCLOHEPTA-[3,2-F]BENZOFURAN-1-IL) AND ITS APPLICATION | 2013 |
|
RU2538982C1 |
| COMPOUNDS FOR TREATING CANCER | 2011 |
|
RU2609018C2 |
| GLP-1 RECEPTOR AGONISTS AND USE THEREOF | 2019 |
|
RU2769715C1 |
| NOVEL HYDROPHILIC DERIVATIVES OF 2-ARYL-4-QUINOLONES AS ANTICANCER AGENTS | 2007 |
|
RU2424245C2 |
| SUBSTITUTED 2-METHYLIDEN-5-(PHENYLAMINO)-2,3-DIHYDROTIOPHEN-3-ONE FOR TREATMENT OF LEUKEMIAS WITH TRANSLOCATIONS OF MLL-GENE AND OTHER ONCOLOGICAL DISEASES | 2017 |
|
RU2656603C1 |
| SUBSTITUTED 4-{[4-(3,3-DIOXIDO-1,3-BENZOXATHIOL-6-YL)ARYLOXY]METHYL}PIPERIDINES AS GPR119 RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCING AND USING THEM | 2014 |
|
RU2576037C1 |
